AVONEX® (interferon beta-1a) | Official Patient Site
AVONEX is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. It is not known if AVONEX is safe and effective in children. Important Safety Information Who should not use AVONEX?
How to Take AVONEX® (interferon beta-1a)
Find important information on the dosing and administration of AVONEX®, including instructions on using the AVONEX PEN®. See Safety and Prescribing Info.
Official Healthcare Professional Site | AVONEX® (interferon beta-1a)
AVONEX® (interferon beta-1a) is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Why Choose AVONEX® (interferon beta-1a)
AVONEX is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults.
AVONEX is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Starting AVONEX® (interferon beta-1a)
AVONEX is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults.
AVONEX is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. It is not known if AVONEX is safe and effective in children. Do not take AVONEX if you:
AVONEX® (interferon beta-1a) - Safety and Side Effects
Learn more about the most common and potential serious side effects with AVONEX® treatment. See Safety and Prescribing Info.
Pivotal Trials Information | AVONEX® (interferon beta-1a)
AVONEX® (interferon beta-1a) is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Financial and insurance assistance - AVONEX® (interferon beta-1a)
Explore financial support & connect with a Biogen Support Coordinator to learn about coverage options for AVONEX®. See Safety and Prescribing Info. Prescribing Information